ECSP034864A - A PDE4 INHIBITOR AND AN ANTI-POLINERGIC AGENT IN COMBINATION TO TREAT OBSTRUCTIVE DISEASES OF RESPIRATORY ROADS - Google Patents

A PDE4 INHIBITOR AND AN ANTI-POLINERGIC AGENT IN COMBINATION TO TREAT OBSTRUCTIVE DISEASES OF RESPIRATORY ROADS

Info

Publication number
ECSP034864A
ECSP034864A ECSP034864A ECSP034864A EC SP034864 A ECSP034864 A EC SP034864A EC SP034864 A ECSP034864 A EC SP034864A EC SP034864 A ECSP034864 A EC SP034864A
Authority
EC
Ecuador
Prior art keywords
combination
agent
polinergic
pde4 inhibitor
obstructive diseases
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Michael Yeadon
John Wesley Watson
Roisin A Armstrong
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ECSP034864A publication Critical patent/ECSP034864A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se relaciona con una combinación de un inhibidor selectivo de PDE4 y un agente anticolinérgico para la administración simultánea, secuencial o por separado por la vía inhalada en el tratamiento de una enfermedad obstructiva de las vías respiratorias u otras enfermedades inflamatorias, con la condición de que el agente anticolinérgico no sea una del tiotropioThe present invention relates to a combination of a selective PDE4 inhibitor and an anticholinergic agent for simultaneous, sequential or separate administration by the inhaled route in the treatment of an obstructive airway disease or other inflammatory diseases, with the condition that the anticholinergic agent is not one of the tiotropium

ECSP034864 2001-05-25 2003-11-25 A PDE4 INHIBITOR AND AN ANTI-POLINERGIC AGENT IN COMBINATION TO TREAT OBSTRUCTIVE DISEASES OF RESPIRATORY ROADS ECSP034864A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29360601P 2001-05-25 2001-05-25

Publications (1)

Publication Number Publication Date
ECSP034864A true ECSP034864A (en) 2004-01-28

Family

ID=34699736

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP034864 ECSP034864A (en) 2001-05-25 2003-11-25 A PDE4 INHIBITOR AND AN ANTI-POLINERGIC AGENT IN COMBINATION TO TREAT OBSTRUCTIVE DISEASES OF RESPIRATORY ROADS

Country Status (4)

Country Link
EC (1) ECSP034864A (en)
PY (1) PY0212139A (en)
SV (1) SV2003001056A (en)
ZA (1) ZA200308602B (en)

Also Published As

Publication number Publication date
PY0212139A (en) 2004-07-01
SV2003001056A (en) 2003-02-03
ZA200308602B (en) 2005-02-04

Similar Documents

Publication Publication Date Title
CR7152A (en) A PDE4 INHIBITOR AND A COMBINATION ANTI-POLINERGIC AGENT TO TREAT OBSTRUCTIVE DISEASES OF RESPIRATORY ROADS.
CO5540324A2 (en) AN A2A AGONIST IN COMBINATION WITH AN ANTI-POLINERGIC AGENT FOR THE TREATMENT OF AIRWAY OBSTRUCTIVE DISEASES
CO5550426A2 (en) NOVEDOUS THERAPEUTIC METHOD
ECSP034620A (en) ORGANIC MIXTURES OR COMPOUNDS FOR THE TREATMENT OF RESPIRATORY ROAD DISEASES
CL2004001170A1 (en) INHALABLE PHARMACEUTICAL COMBINATION CONTAINING (A) FORMOTEROL, OR A SALT, OR A SOLVATE OF IT OR THE SALT AND (B) MOMETASONE FUROATE; PHARMACEUTICAL CASE THAT UNDERSTANDS IT; AND ITS USE IN THE THERAPY OF AN INFLAMMATORY OR OBSTRUCTIVE DISEASE OF THE V
BRPI0410503A (en) use of ivermectin for the manufacture of a topical pharmaceutical composition, topical composition and use of the composition
ATE330589T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING RESVERATROL FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE RESPIRATORY TRACT
AR008293A1 (en) COMPOSITION THAT INCLUDES AN ANTIHISTAMINIC AMOUNT FOR THE TREATMENT OF ALLERGIC RESPONSES OF THE SUPERIOR RESPIRATORY TRACT
CO4340692A1 (en) MOMETASONE FUROATE FOR THE TREATMENT OF LUNG DISEASES AND RESPIRATORY TRACT
CY1117571T1 (en) ANTI-CLINICAL AND COMPETITIVE ANTI-CLINICAL COMPETITION RELATIONS FOR THE RESCUE OF RESPIRATORY DISEASES
UY27656A1 (en) NICOTINAMIDE DERIVATIVES AND A COMBINATION TIOTROPIO SALT FOR THE TREATMENT OF DISEASES
UY27658A1 (en) NICOTINAMIDE DERIVATIVES AND A COMBINATION TIOTROPIO SALT FOR THE TREATMENT OF DISEASES
MXPA03011702A (en) Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases.
BR0206549A (en) Use of flumazenil in the production of a drug for the treatment of alcohol dependence
AR031969A1 (en) PREVENTIVE AND / OR THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES OF RESPIRATORY ROADS
NO20073909L (en) Nebulized formulation
ECSP034864A (en) A PDE4 INHIBITOR AND AN ANTI-POLINERGIC AGENT IN COMBINATION TO TREAT OBSTRUCTIVE DISEASES OF RESPIRATORY ROADS
WO2005011602A3 (en) Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
HRP20050579B1 (en) New synergistic combination comprising roflumilast and formoterol
UY27307A1 (en) A PDE4 INHIBITOR AND AN ANTI-POLYNERGIC AGENT IN COMBINATION TO TREAT OBSTRUCTIVE DISEASES OF RESPIRATORY ROUTES
UY27566A1 (en) PHARMACEUTICAL COMBINATION
UY27565A1 (en) PHARMACEUTICAL COMBINATION
ECSP045142A (en) PHARMACEUTICAL COMBINATION
ECSP034863A (en) AN A2A AGONIST IN COMBINATION WITH AN ANTI-POLINERGIC AGENT FOR THE TREATMENT OF AIRWAY OBSTRUCTIVE DISEASES
CO5690571A2 (en) SYNERGIC COMBINATION INCLUDING ROFLUMILAS AND (R, R) -FORMOTEROL